Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05687799

Fatigue, Sleep and Quality of Life in Parkinson's Patients

Conditions: Idiopathic Parkinson's Disease

Sex: All
Ages: 50 Years – N/A
Enrollment: 39
Sponsor: Nigde Omer Halisdemir University

Location: Turkey

Summary

Parkinson's Disease (PD) is a neurodegenerative disease characterized by chronic and progressive loss of dopaminergic neurons in the substantia nigra (SN) pars compacta. Sleep disturbances and fatigue are very common problems in Parkinson's patients. He reported that the frequency of fatigue was 47% in patients with a disease duration of less than five years and 70% in patients with a disease duration of more than five years. Fatigue in PD has been found to be associated with decreased physical activity, decreased functionality, sleep disorders, gait disturbances, motor findings, autonomic findings, increased levodopa dose, and motor fluctuations. Motor and non-motor symptoms in Parkinson's patients affect the individual's ability to perform activities of daily living independently. Impairments in functional status lead to negative consequences on quality of life. PD affects the individual not only physically, but also psychologically and socially.The neutrophil/lymphocyte ratio is a marker of peripheral inflammation. The relationship of peripheral inflammation to quality of sleep, quality of life and fatigue in individuals is unclear. The aim of this study was to investigation fatigue, quality of sleep and quality of life, and the relationship between neutrophil/lymphocyte ratio in Parkinson's patients.

Eligibility Criteria

Inclusion Criteria:Being diagnosed with idiopathic Parkinson's diseaseHealthy individuals who do not have musculoskeletal disease or any neurological disease that may affect assessmentsOlder than 50 years oldVolunteer to participate in the studyGrade 1-3 on the Modified Hoehn-Yahr ScaleTo have a score above 24 in the Standardized Mini Mental TestTo have a hemogram follow-up in the last 1 month before the date of participation in the study.Being able to walk independently on flat groundExclusion Criteria:Having an additional or psychiatric disease other than Parkinson's diseaseLack of cooperationPresence of orthopedic problems (such as fractures, osteoporosis, osteomyelitis)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05687799). StuddyBuddy aggregates publicly available trial information.